Therapeutic Drug Monitoring (TDM): An Aspect of Clinical Pharmacology and Pharmacy Practice
Abstract
Therapeutic drug monitoring or TDM is the clinical pharmacology of measuring specific drugs at designated intervals to uphold a constant level of drug in a patient’s blood circulation, thereby optimizing individual dosage regimens. TDM becomes necessary only for the categories of drug with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. On the basis of drug dose and plasma drug concentration or between concentration and therapeutic effects the assumption of TDM is done. TDM initiates when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient individuality such as age, weight, organ function, and concomitant drug therapy. Certain factors need to be considered while interpretation of concentration measurement which include sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. Use of appropriate concentrations of drug to manage medications to optimize clinical outcomes in patients in various clinical conditions is the primary goal of TDM.
Keywords: Therapeutic drug monitoring, pharmacokinetics, toxicity, analytical methodology
Cite this Article
Iswar Hazarika. Therapeutic drug monitoring (TDM): an aspect of clinical pharmacology and pharmacy practice. Research & Reviews: Journal of Pharmacology. 2015; 5(3): 27–34p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |